Category Archives: Bulletin

CLSA Board Visits Capitol Hill, Annual DC Spring Reception, CLSA Welcomes 14 New Members, Events in June, CLSA Board and Staff Continues Expansion

By: Sara Radcliffe CLSA President & CEO CLSA – California Life Sciences Association May 25, 2017    CLSA Board Goes to Washington to Meet with Members of Congress, Discuss Biomedical Innovation As advocacy is a core activity critical to our organization’s mission, I was honored to join 19 CLSA board members on Capitol Hill on May 3 for … Continue reading CLSA Board Visits Capitol Hill, Annual DC Spring Reception, CLSA Welcomes 14 New Members, Events in June, CLSA Board and Staff Continues Expansion

FAST & Fellows Round-Up

Read the latest in FAST and Fellows news: On April 27, BridgeBio Pharma announced the launch of Eidos Therapeutics, a CLSI 2016 FAST biopharmaceutical company developing a novel small-molecule treatment for transthyretin (TTR) amyloidosis. BridgeBio has committed $27 million and seasoned R&D executives to advance Eidos’ lead compound, AG10.   AG10 was discovered and initially developed by Eidos’ co-founders Isabella Graef, … Continue reading FAST & Fellows Round-Up

Combining an Unparalleled AI Platform with a Seasoned Pharma Team, Evince Biosciences Reimagines Drug Discovery and takes on Cancer Immunotherapy

By Paulo Rangel President & CEO of Evince Biosciences, Inc. Evince Biosciences is a next generation drug discovery company, using a compelling machine learning approach to reimagining drug discovery. Our first program targets toll-like receptor 7 (TLR7) for cancer immunotherapy. Simply stated, without a dramatic increase in R&D productivity, today’s pharmaceutical industry cannot sustain sufficient … Continue reading Combining an Unparalleled AI Platform with a Seasoned Pharma Team, Evince Biosciences Reimagines Drug Discovery and takes on Cancer Immunotherapy

CLSA Announces Bay Area “Giants of Sciences” Partnership with KNBR to Support Life Sciences Education

We are excited to announce that earlier this month several CLSA member companies, in conjunction with CLSA, CLSI and KNBR, launched the “Giants of Science” competition in San Francisco to award three $20,000 science program grants to Bay Area high schools who submit an application and video explaining why they need the grant and what … Continue reading CLSA Announces Bay Area “Giants of Sciences” Partnership with KNBR to Support Life Sciences Education

CLSA Applauds Confirmation of Dr. Scott Gottlieb as New FDA Commissioner

WASHINGTON & BAY AREA, May 9, 2017 – California Life Sciences Association (CLSA), the state’s premier public policy and business solutions organization representing the California life sciences industry, today commended the U.S. Senate’s confirmation of Scott Gottlieb, M.D., as the new commissioner of the U.S. Food and Drug Administration (FDA). As the key federal agency … Continue reading CLSA Applauds Confirmation of Dr. Scott Gottlieb as New FDA Commissioner